Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
Status:
Completed
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
This trial was to determine whether giving low-dose indomethacin to infants weight 500 to 999
grams (approximately 1 to 2 pounds) at birth improves their survival without cerebral palsy
or developmental problems at 18 to 22 months of age.
Phase:
Phase 3
Details
Lead Sponsor:
NICHD Neonatal Research Network
Collaborators:
Medical Research Council of Canada National Center for Research Resources (NCRR)